Jiang Geng

1.4k total citations · 1 hit paper
46 papers, 779 citations indexed

About

Jiang Geng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiang Geng has authored 46 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiang Geng's work include RNA modifications and cancer (11 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer-related molecular mechanisms research (7 papers). Jiang Geng is often cited by papers focused on RNA modifications and cancer (11 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer-related molecular mechanisms research (7 papers). Jiang Geng collaborates with scholars based in China, United States and Tanzania. Jiang Geng's co-authors include Yu‐Shui Ma, Da Fu, Bailing Li, Guanxin Zhang, Jibin Liu, Min Liu, Likun Hou, Haimin Lu, Wen Li and Sun Feng and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and British Journal of Cancer.

In The Last Decade

Jiang Geng

41 papers receiving 766 citations

Hit Papers

Liquid biopsy in lung cancer: significance in diagnostics... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiang Geng China 15 392 325 213 154 117 46 779
Jianjun Han China 16 405 1.0× 275 0.8× 128 0.6× 281 1.8× 175 1.5× 61 936
Yongfu Xiong China 19 516 1.3× 312 1.0× 211 1.0× 254 1.6× 102 0.9× 56 1.0k
Haoran Li China 14 491 1.3× 345 1.1× 187 0.9× 336 2.2× 169 1.4× 81 1.1k
Yu Bai China 16 451 1.2× 253 0.8× 159 0.7× 228 1.5× 83 0.7× 49 848
Tingting Zhao China 17 278 0.7× 224 0.7× 143 0.7× 177 1.1× 89 0.8× 35 672
Xuehua Zhu China 18 519 1.3× 168 0.5× 235 1.1× 202 1.3× 103 0.9× 44 1.0k
Aiqin Gu China 18 489 1.2× 314 1.0× 262 1.2× 254 1.6× 55 0.5× 65 1.0k
Hongliang Zhang China 15 494 1.3× 141 0.4× 105 0.5× 291 1.9× 75 0.6× 52 888

Countries citing papers authored by Jiang Geng

Since Specialization
Citations

This map shows the geographic impact of Jiang Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Geng more than expected).

Fields of papers citing papers by Jiang Geng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Geng. The network helps show where Jiang Geng may publish in the future.

Co-authorship network of co-authors of Jiang Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang Geng. A scholar is included among the top collaborators of Jiang Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang Geng. Jiang Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geng, Jiang, Jiaxin Li, Dongyu Li, et al.. (2025). Harnessing microalgae for protein production: advances, functional properties, and industrial potential. Future Foods. 12. 100776–100776.
2.
Fang, Wen‐Feng, Wensheng Zhao, Lin Wang, et al.. (2025). 57P: Safety and efficacy of aumolertinib treatment in patients with advanced NSCLC harboring 20ins and uncommon EGFR mutations (AIM). Journal of Thoracic Oncology. 20(3). S45–S46. 1 indexed citations
5.
Zhang, Zhijin, Wentao Zhang, Huan Wang, et al.. (2024). Immunosuppressive role of benzo[a]pyrene exposure in prostate cancer progression. Journal of Environmental Sciences. 156. 185–199.
6.
Mao, Weipu, Kangjie Xu, Jiang Geng, et al.. (2024). Single-cell RNA sequencing and spatial transcriptomics of bladder Ewing sarcoma. iScience. 27(10). 110921–110921.
7.
Shen, Fang‐Fang, Xinyu Wu, Jiang Geng, Wei Guo, & Jianchun Duan. (2024). Prognostic factors for resected invasive mucinous lung adenocarcinoma: a systematic review and meta-analysis. BMC Cancer. 24(1). 1317–1317. 1 indexed citations
8.
Liu, Ji, Libin Zou, Zhijin Zhang, et al.. (2024). Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8+ T cell activity in prostate cancer. Molecular Biomedicine. 5(1). 67–67. 1 indexed citations
9.
Zhang, Zhijin, Ji Liu, Yang Wu, et al.. (2024). The functions and mechanisms of RNA modification in prostate: Current status and future perspectives. Frontiers in Genetics. 15. 1380746–1380746. 2 indexed citations
10.
Geng, Jiang, et al.. (2023). Nattokinase enhances the sensitivity of cancer cells to oxaliplatin through mitochondrial pathway and induction of apoptosis. Arabian Journal of Chemistry. 17(1). 105478–105478. 2 indexed citations
11.
Ma, Yu‐Shui, Jiewei Lin, Jiang Geng, et al.. (2023). Whole-exome and targeted gene sequencing of large-cell lung carcinoma reveals recurrent mutations in the PI3K pathway. British Journal of Cancer. 129(2). 366–373. 3 indexed citations
12.
Feng, Jian, Chang Xu, Yi Wang, et al.. (2022). Prognosis of lung cancer with simple brain metastasis patients and establishment of survival prediction models: a study based on real events. BMC Pulmonary Medicine. 22(1). 162–162. 5 indexed citations
13.
Zhang, Jiajia, Yu‐Shui Ma, Yi Shi, et al.. (2021). Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression. Disease Markers. 2021. 1–14. 15 indexed citations
14.
Ma, Yu‐Shui, Bowen Shi, Haimin Lu, et al.. (2021). MicroRNA-499 serves as a sensitizer for lung cancer cells to radiotherapy by inhibition of CK2α-mediated phosphorylation of p65. Molecular Therapy — Oncolytics. 21. 171–182. 4 indexed citations
15.
Wei, Feng, Xianling Guo, Haidong Huang, et al.. (2018). Polymorphism rs3819102 in thymidylate synthase and environmental factors: effects on lung cancer in Chinese population. Current Problems in Cancer. 43(1). 66–74. 6 indexed citations
16.
Geng, Jiang, et al.. (2017). Overexpression of CKAP4 is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma and Functions via Cyclin B Signaling. Journal of Cancer. 8(19). 4018–4026. 14 indexed citations
17.
Su, Shifeng, Xiaoyu Chen, Jiang Geng, et al.. (2016). Melanoma antigen-A11 regulates substrate-specificity of Skp2-mediated protein degradation. Molecular and Cellular Endocrinology. 439. 1–9. 14 indexed citations
18.
Li, Bailing, Jiang Geng, Guanxin Zhang, et al.. (2014). Intake of vegetables and fruit and risk of esophageal adenocarcinoma: a meta-analysis of observational studies. European Journal of Nutrition. 53(7). 1511–1521. 34 indexed citations
19.
Geng, Jiang, Xiao‐Peng Zhang, Bo Peng, et al.. (2013). Statin use and risk of bladder cancer: a meta-analysis. Cancer Causes & Control. 24(4). 769–776. 35 indexed citations
20.
Geng, Jiang, Jie Fan, Haowen Jiang, et al.. (2009). Elevated serum soluble Fas ligand is a promising marker of testicular toxicity induced by epirubicin in rats. Toxicology Letters. 186(2). 96–103. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026